Reuters: FDA wants more study of diabetes drug heart risk

[NaDiNe]

FDA wants more study of diabetes drug heart risk
      

WASHINGTON (Reuters) - Drug companies should more thoroughly study the potential heart risks of new diabetes medicines, U.S. health officials said on Wednesday.<div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login